Infantile-Onset Paroxysmal Movement Disorder and Episodic Ataxia Associated with a TBC1D24 Mutation

Abstract

Mutations that disrupt the TBC1D24 presynaptic protein have been implicated in various neurological disorders including epilepsy, chronic encephalopathy, DOORS (deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures) syndrome, nonsyndromic hearing loss, and myoclonus. We present the case of a 22-month-old male with infantile-onset paroxysmal episodes of facial and limb myoclonus. The episodes were linked to biallelic variants in exon 2 of the TBC1D24 gene that lead to amino acid changes (c.304C >T/p.Pro102Ser and c.410T > C/p.Val137Ala), each variant being inherited from a parent. Follow-up imaging in adolescence revealed widened right cerebellar sulci. We discuss the evolving landscape of TBC1D24 associated phenotypes; this case adds to a growing body of evidence linking this gene to movement disorders in children.

Keywords

TBC1D24 - genetics - infancy - cerebellum - episodic ataxia - myoclonus

• References

• 1 Mucha BE, Hennekam RCM, Sisodiya S, Campeau PM. TBC1D24-related disorders. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25719194 . Accessed April 5, 2019
• 2 Balestrini S, Milh M, Castiglioni C. , et al. TBC1D24 genotype-phenotype correlation: Epilepsies and other neurologic features. Neurology 2016; 87 (01) 77-85
• 3 Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 2013; Chapter 7 (Unit 7): 20
• 4 Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 2010; 7 (08) 575-576
• 5 Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC. SIFT missense predictions for genomes. Nat Protoc 2016; 11 (01) 1-9
• 6 Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 2015; 31 (16) 2745-2747
• 7 Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014; 46 (03) 310-315
• 8 Fischer B, Lüthy K, Paesmans J. , et al. Skywalker-TBC1D24 has a lipid-binding pocket mutated in epilepsy and required for synaptic function. Nat Struct Mol Biol 2016; 23 (11) 965-973
• 9 Corbett MA, Bahlo M, Jolly L. , et al. A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24. Am J Hum Genet 2010; 87 (03) 371-375
• 10 Guven A, Tolun A. TBC1D24 truncating mutation resulting in severe neurodegeneration. J Med Genet 2013; 50 (03) 199-202
• 11 Doummar D, Mignot C, Apartis E. , et al. A novel homozygous TBC1D24 mutation causing multifocal myoclonus with cerebellar involvement. Mov Disord 2015; 30 (10) 1431-1432
• 12 Ngoh A, Bras J, Guerreiro R. , et al. Tbc1d24 mutations in a sibship with multifocal polymyoclonus. Tremor Other Hyperkinet Mov (N Y) 2017; 7: 452
• 13 Li WH, Zhou SZ, Zhang LM. , et al. [Novel compound heterozygous TBC1D24 mutations in a boy with infantile focal myoclonic epilepsy and literature review]. Zhonghua Er Ke Za Zhi 2017; 55 (01) 50-53
• 14 Campeau PM, Kasperaviciute D, Lu JT. , et al. The genetic basis of DOORS syndrome: an exome-sequencing study. Lancet Neurol 2014; 13 (01) 44-58
• 15 Afawi Z, Mandelstam S, Korczyn AD. , et al. TBC1D24 mutation associated with focal epilepsy, cognitive impairment and a distinctive cerebro-cerebellar malformation. Epilepsy Res 2013; 105 (1,2): 240-244